BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kitching AR, Anders HJ, Basu N, Brouwer E, Gordon J, Jayne DR, Kullman J, Lyons PA, Merkel PA, Savage COS, Specks U, Kain R. ANCA-associated vasculitis. Nat Rev Dis Primers 2020;6:71. [PMID: 32855422 DOI: 10.1038/s41572-020-0204-y] [Cited by in Crossref: 51] [Cited by in F6Publishing: 130] [Article Influence: 25.5] [Reference Citation Analysis]
Number Citing Articles
1 Kessler N, Viehmann SF, Krollmann C, Mai K, Kirschner KM, Luksch H, Kotagiri P, Böhner AMC, Huugen D, de Oliveira Mann CC, Otten S, Weiss SAI, Zillinger T, Dobrikova K, Jenne DE, Behrendt R, Ablasser A, Bartok E, Hartmann G, Hopfner KP, Lyons PA, Boor P, Rösen-Wolff A, Teichmann LL, Heeringa P, Kurts C, Garbi N. Monocyte-derived macrophages aggravate pulmonary vasculitis via cGAS/STING/IFN-mediated nucleic acid sensing. J Exp Med 2022;219:e20220759. [PMID: 35997679 DOI: 10.1084/jem.20220759] [Reference Citation Analysis]
2 Ge S, Zhu X, Xu Q, Wang J, An C, Hu Y, Yang F, Wang X, Yang Y, Chen S, Jin R, Li H, Peng X, Liu Y, Xu J, Zhu M, Shuai Z. Neutrophils in ANCA-associated vasculitis: Mechanisms and implications for management. Front Pharmacol 2022;13:957660. [DOI: 10.3389/fphar.2022.957660] [Reference Citation Analysis]
3 Holers VM. Contributions of animal models to mechanistic understandings of antibody‐dependent disease and roles of the amplification loop. Immunological Reviews. [DOI: 10.1111/imr.13136] [Reference Citation Analysis]
4 Pecher A, Henes M, Henes JC. Optimal management of ANCA-associated vasculitis before and during pregnancy: current perspectives. Arch Gynecol Obstet. [DOI: 10.1007/s00404-022-06744-5] [Reference Citation Analysis]
5 Puéchal X, Guillevin L. How best to manage relapse and remission in ANCA-associated vasculitis. Expert Rev Clin Immunol 2022. [PMID: 36102147 DOI: 10.1080/1744666X.2022.2122954] [Reference Citation Analysis]
6 Xu L, Kant S, Aqeel F, Antiochos B, Li C, Snopkowski C, Seo P, Gapud EJ, Muthukumar T, Geetha D. Urinary cell mRNA profiling distinguishes disease activity in antineutrophil cytoplasmic antibody-associated glomerulonephritis. J Nephrol 2022. [PMID: 36083534 DOI: 10.1007/s40620-022-01460-4] [Reference Citation Analysis]
7 Wijsenbeek M, Suzuki A, Maher TM. Interstitial lung diseases. The Lancet 2022;400:769-86. [DOI: 10.1016/s0140-6736(22)01052-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 van Eeden C, Osman MS, Cohen Tervaert JW. Fatigue in ANCA-associated vasculitis (AAV) and systemic sclerosis (SSc): similarities with Myalgic encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). A critical review of the literature. Expert Rev Clin Immunol 2022;:1-22. [PMID: 36045606 DOI: 10.1080/1744666X.2022.2116002] [Reference Citation Analysis]
9 Barroso Hernández S, Rodríguez Sabillón JA, Álvarez López Á, García de Vinuesa Calvo E, Calvo Cano A, Robles Pérez-Monteoliva NR. Cytomegalovirus disease in immunosuppressed patients with necrotizing pauci-immune glomerulonephritis. Med Clin (Barc) 2022:S0025-7753(22)00415-8. [PMID: 36031453 DOI: 10.1016/j.medcli.2022.07.009] [Reference Citation Analysis]
10 Martin K, Deleveaux S, Cunningham M, Ramaswamy K, Thomas B, Lerma E, Madariaga H. The presentation, etiologies, pathophysiology, and treatment of pulmonary renal syndrome: A review of the literature. Dis Mon 2022;:101465. [PMID: 36008166 DOI: 10.1016/j.disamonth.2022.101465] [Reference Citation Analysis]
11 Tang J, Liao Z, Luo L, Deng S, Jiang Y, Wang F, Hu X, Yin H, Gong G, Feng J, Li X. CX3CL1-induced CD16+ monocytes extravasation in myeloperoxidase-ANCA-associated vasculitis correlates with renal damage. Front Immunol 2022;13:929244. [DOI: 10.3389/fimmu.2022.929244] [Reference Citation Analysis]
12 Krebold AK, Schaller T, Appenzeller M, Schwaiblmair M, Kircher M, Bundschuh RA, Lapa C, Dierks A. [18F]FDG PET/CT guided biopsy confirms diagnosis of granulomatosis with polyangiitis. Nuklearmedizin 2022. [PMID: 35977670 DOI: 10.1055/a-1907-4248] [Reference Citation Analysis]
13 Klas K, Ondracek AS, Hofbauer TM, Mangold A, Pfisterer K, Laggner M, Copic D, Direder M, Bormann D, Ankersmit HJ, Mildner M. The Effect of Paracrine Factors Released by Irradiated Peripheral Blood Mononuclear Cells on Neutrophil Extracellular Trap Formation. Antioxidants 2022;11:1559. [DOI: 10.3390/antiox11081559] [Reference Citation Analysis]
14 Cerullo D, Rottoli D, Corna D, Abbate M, Benigni A, Remuzzi G, Zoja C. Add-On Cyclic Angiotensin-(1-7) with Cyclophosphamide Arrests Progressive Kidney Disease in Rats with ANCA Associated Glomerulonephritis. Cells 2022;11:2434. [PMID: 35954280 DOI: 10.3390/cells11152434] [Reference Citation Analysis]
15 Sun K, Fisher JH, Pagnoux C. Interstitial Lung Disease in ANCA-Associated Vasculitis: Pathogenic Considerations and Impact for Patients' Outcomes. Curr Rheumatol Rep 2022;24:259-67. [PMID: 35794350 DOI: 10.1007/s11926-022-01078-2] [Reference Citation Analysis]
16 Shochet L, Kitching AR. Identifying Antigen-Specific T Cells in ANCA-Associated Vasculitis: A Glimpse of the Future? J Am Soc Nephrol 2022;33:1435-7. [PMID: 35906086 DOI: 10.1681/ASN.2022060668] [Reference Citation Analysis]
17 Wienkamp A, Erpenbeck L, Rossaint J. Platelets in the NETworks interweaving inflammation and thrombosis. Front Immunol 2022;13:953129. [DOI: 10.3389/fimmu.2022.953129] [Reference Citation Analysis]
18 Rani L, Singh J, Sharma A, Singh H, Verma I, Panda NK, Minz RW. Anti-staphylococcal responses and their relationship with HLA-DR-DQ polymorphism in granulomatosis with polyangiitis: a preliminary evidence of association with disease outcome. Clin Exp Med 2022. [PMID: 35881260 DOI: 10.1007/s10238-022-00865-6] [Reference Citation Analysis]
19 Christodoulou M, Iatridi F, Chalkidis G, Lioulios G, Nikolaidou C, Badis K, Fylaktou A, Papagianni A, Stangou M. ANCA-Associated Vasculitis May Result as a Complication to Both SARS-CoV-2 Infection and Vaccination. Life (Basel) 2022;12:1072. [PMID: 35888159 DOI: 10.3390/life12071072] [Reference Citation Analysis]
20 Lee LE, Jeong W, Park YB, Jeong SJ, Lee SW. Clinical Significance of Antineutrophil Cytoplasmic Antibody Positivity in Patients Infected with SARS-CoV-2. J Clin Med 2022;11:4152. [PMID: 35887916 DOI: 10.3390/jcm11144152] [Reference Citation Analysis]
21 Pfister H. Neutrophil Extracellular Traps and Neutrophil-Derived Extracellular Vesicles: Common Players in Neutrophil Effector Functions. Diagnostics (Basel) 2022;12:1715. [PMID: 35885618 DOI: 10.3390/diagnostics12071715] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Marceau F, Petitclerc E. C5a receptor antagonism coming of age for vascular pathology. Int Immunopharmacol 2022;110:109042. [PMID: 35843145 DOI: 10.1016/j.intimp.2022.109042] [Reference Citation Analysis]
23 Yaseen K, Mandell BF. ANCA Associated Vasculitis (AAV): A Review for Internists. Postgrad Med 2022. [PMID: 35831990 DOI: 10.1080/00325481.2022.2102368] [Reference Citation Analysis]
24 Yu L, Huang G, Lu Z, Wang J, Gu W, Li J, Mao J. Glomerular IgA Deposition and Serum Antineutrophil Cytoplasmic Antibody Positivity in a Child With Dystrophic Epidermolysis Bullosa: Case Report and Literature Review. Front Pediatr 2022;10:939069. [DOI: 10.3389/fped.2022.939069] [Reference Citation Analysis]
25 Ahn SS, Ha JW, Park YB, Lee SW. BVAS version 3 and BVAS/GPA: standing on the same line? Clin Rheumatol 2022. [PMID: 35804274 DOI: 10.1007/s10067-022-06267-z] [Reference Citation Analysis]
26 Al-soudi A, Vegting Y, Klarenbeek PL, Hilhorst ML. Do Relapses Follow ANCA Rises? A Systematic Review and Meta-Analysis on the Value of Serial ANCA Level Evaluation. Front Med 2022;9:844112. [DOI: 10.3389/fmed.2022.844112] [Reference Citation Analysis]
27 Kermani TA, Warrington KJ, Dua AB. Treatment Guidelines in Vasculitis. Rheumatic Disease Clinics of North America 2022. [DOI: 10.1016/j.rdc.2022.03.006] [Reference Citation Analysis]
28 Michailidou D, Duvvuri B, Kuley R, Cuthbertson D, Grayson PC, Khalidi NA, Koening CL, Langford CA, McAlear CA, Moreland LW, Pagnoux C, Seo P, Specks U, Sreih AG, Warrington KJ, Mustelin T, Monach PA, Merkel PA, Lood C. Neutrophil activation in patients with anti-neutrophil cytoplasmic autoantibody-associated vasculitis and large-vessel vasculitis. Arthritis Res Ther 2022;24:160. [PMID: 35768848 DOI: 10.1186/s13075-022-02849-z] [Reference Citation Analysis]
29 He X, Wen Y, Hu R, Wu H, Ye W, Yue C, Qin Y, Xia P, Chen L. Interstitial nephritis without glomerulonephritis in ANCA-associated vasculitis: a case series and literature review. Clin Rheumatol 2022. [PMID: 35759125 DOI: 10.1007/s10067-022-06264-2] [Reference Citation Analysis]
30 Yun JD, Lee JH, Pyo JY, Ahn SS, Song JJ, Park YB, Lee SW. Birmingham vasculitis activity score and the short form 36-item health survey predict current depressive disorders in patients with antineutrophil cytoplasmic antibody-associated vasculitis during the SARS-CoV-2 pandemic. Z Rheumatol 2022. [PMID: 35748925 DOI: 10.1007/s00393-022-01233-1] [Reference Citation Analysis]
31 Van Gool IC, Kers J, Bakker JA, Rotmans JI, Teng YKO, Bauer MP. Antineutrophil cytoplasmic antibodies in infective endocarditis: a case report and systematic review of the literature. Clin Rheumatol 2022. [PMID: 35732985 DOI: 10.1007/s10067-022-06240-w] [Reference Citation Analysis]
32 Lee JH, Yun JD, Whang JY, Pyo JY, Ahn SS, Song JJ, Park YB, Lee SW. Predicting the depressive status using empirical dietary inflammatory index in patients with antineutrophil cytoplasmic antibody-associated vasculitis. J Clin Lab Anal 2022;:e24543. [PMID: 35719000 DOI: 10.1002/jcla.24543] [Reference Citation Analysis]
33 Ren J, Ding Y, Zhao J, Sun Y. Bronchiectasis in patients with antineutrophil cytoplasmic antibody-associated vasculitis: a case control study on clinical features and prognosis. Expert Rev Respir Med 2022;:1-9. [PMID: 35687867 DOI: 10.1080/17476348.2022.2088512] [Reference Citation Analysis]
34 McDermott G, Fu X, Cook C, Ahola C, Doliner B, Hanberg J, Stone JH, Choi HK, Zhang Y, Wallace ZS. The effect of achieving serological remission on subsequent risk of relapse, end-stage renal disease and mortality in ANCA-associated vasculitis: a target trial emulation study. Ann Rheum Dis 2022:annrheumdis-2022-222439. [PMID: 35697489 DOI: 10.1136/annrheumdis-2022-222439] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
35 Wang Y, Liu X, Xia P, Li Z, FuChen X, Shen Y, Yu P, Zhang J. The Regulatory Role of MicroRNAs on Phagocytes: A Potential Therapeutic Target for Chronic Diseases. Front Immunol 2022;13:901166. [PMID: 35634335 DOI: 10.3389/fimmu.2022.901166] [Reference Citation Analysis]
36 Xu J, Zhao H, Wang S, Zheng M, Shuai Z. Elevated Level of Serum Interleukin-21 and Its Influence on Disease Activity in Anti-Neutrophil Cytoplasmic Antibodies Against Myeloperoxidase-Associated Vasculitis. J Interferon Cytokine Res 2022;42:290-300. [PMID: 35416717 DOI: 10.1089/jir.2022.0014] [Reference Citation Analysis]
37 Ha JW, Pyo JY, Ahn SS, Song JJ, Park Y, Lee S, Xu B. Incidence and Patterns of Interstitial Lung Disease and Their Clinical Impact on Mortality in Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Korean Single-Centre Observational Study. Journal of Immunology Research 2022;2022:1-7. [DOI: 10.1155/2022/2499404] [Reference Citation Analysis]
38 Shakshouk H, Gibson LE. Cutaneous manifestations of ANCA-associated vasculitis: a retrospective review of 211 cases with emphasis on clinicopathologic correlation and ANCA status. Int J Dermatol 2022. [PMID: 35576100 DOI: 10.1111/ijd.16214] [Reference Citation Analysis]
39 Petrou D, Karagiannis M, Nikolopoulos P, Liapis G, Lionaki S. MPO–ANCA-Positive Granulomatosis with Polyangiitis with Rapidly Progressive Glomerulonephritis and Saddle-Nose Deformity: A Case Report. Antibodies 2022;11:33. [DOI: 10.3390/antib11020033] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
40 Ashraf A, Daloya J, Rana V, Ahmed A, Kaell A. Diagnosing and Managing Clinically Silent Lupus Nephritis and Anti-neutrophil Cytoplasmic Antibody-Associated Vasculitis Overlap Syndrome: A Clinical Challange. Cureus. [DOI: 10.7759/cureus.24624] [Reference Citation Analysis]
41 Dräger S, Jahn K, Vogt M, Hopfer H, Kyburz D, Osthoff M. Reversed halo sign on chest computed tomography in a 33-year old man without immunosuppression. Am J Med 2022:S0002-9343(22)00343-6. [PMID: 35472379 DOI: 10.1016/j.amjmed.2022.04.009] [Reference Citation Analysis]
42 Rousselle A, Sonnemann J, Amann K, Mildner A, Lodka D, Kling L, Bieringer M, Schneider U, Leutz A, Enghard P, Kettritz R, Schreiber A. CSF2-dependent monocyte education in the pathogenesis of ANCA-induced glomerulonephritis. Ann Rheum Dis 2022:annrheumdis-2021-221984. [PMID: 35418479 DOI: 10.1136/annrheumdis-2021-221984] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
43 Liebowitz JE, Konig MF. Joint Pain in a Woman Wearing a Face Mask. JAMA 2022;327:1392-3. [PMID: 35297963 DOI: 10.1001/jama.2022.2644] [Reference Citation Analysis]
44 Sethi S, De Vriese AS, Fervenza FC. Acute glomerulonephritis. The Lancet 2022;399:1646-63. [DOI: 10.1016/s0140-6736(22)00461-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
45 Huang SU, O'Sullivan KM. The Expanding Role of Extracellular Traps in Inflammation and Autoimmunity: The New Players in Casting Dark Webs. Int J Mol Sci 2022;23:3793. [PMID: 35409152 DOI: 10.3390/ijms23073793] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
46 Evangelatos G, Grivas A, Pappa M, Kouna K, Iliopoulos A, Fragoulis GE. Cranial giant cell arteritis mimickers: A masquerade to unveil. Autoimmun Rev 2022;:103083. [PMID: 35341973 DOI: 10.1016/j.autrev.2022.103083] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
47 Puéchal X, Iudici M, Pagnoux C, Cohen P, Hamidou M, Aouba A, Lifermann F, Ruivard M, Aumaître O, Bonnotte B, Maurier F, Le Gallou T, Hachulla E, Karras A, Khouatra C, Jourde-Chiche N, Viallard JF, Blanchard-Delaunay C, Godmer P, Le Quellec A, Quéméneur T, de Moreuil C, Mouthon L, Terrier B, Guillevin L; French Vasculitis Study Group. Comparative study of granulomatosis with polyangiitis subsets according to ANCA status: data from the French Vasculitis Study Group Registry. RMD Open 2022;8:e002160. [PMID: 35296533 DOI: 10.1136/rmdopen-2021-002160] [Reference Citation Analysis]
48 Al-yafeai Z, Horn BJM, Terraccaine W, Jose A, Krishnan P. A Case of Antineutrophil Cytoplasmic Antibodies (ANCA)-Associated Vasculitis Post COVID-19 Vaccination. Cureus. [DOI: 10.7759/cureus.23162] [Reference Citation Analysis]
49 Yamada A, Harada M, Nobuoka T, Yamaguchi A, Sonoda K, Hashimoto K, Kamijo Y. Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis Developing Pancreatic Lesion and Diabetes Mellitus: A Case Report and Review of the Literature. Tohoku J Exp Med 2022;256:161-8. [PMID: 35228453 DOI: 10.1620/tjem.256.161] [Reference Citation Analysis]
50 Lavine N, Ohayon A, Mahroum N. Renal autoimmunity: The role of bacterial and viral infections, an extensive review. Autoimmun Rev 2022;:103073. [PMID: 35245692 DOI: 10.1016/j.autrev.2022.103073] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
51 Kitching AR. Immunoageing within the kidney via injury associated tertiary lymphoid tissue. Kidney International 2022. [DOI: 10.1016/j.kint.2022.03.014] [Reference Citation Analysis]
52 Xia MD, Yu RR, Chen DM. Identification of Hub Biomarkers and Immune-Related Pathways Participating in the Progression of Antineutrophil Cytoplasmic Antibody-Associated Glomerulonephritis. Front Immunol 2021;12:809325. [PMID: 35069594 DOI: 10.3389/fimmu.2021.809325] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
53 Suresh E. The management of anti-neutrophil cytoplasmic antibody-associated vasculitis: what has changed in the last 10 years? Br J Hosp Med. [DOI: 10.12968/hmed.2021.0528] [Reference Citation Analysis]
54 d’Alessandro M, Conticini E, Bergantini L, Cameli P, Cantarini L, Frediani B, Bargagli E. Neutrophil Extracellular Traps in ANCA-Associated Vasculitis and Interstitial Lung Disease: A Scoping Review. Life 2022;12:317. [DOI: 10.3390/life12020317] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
55 Moollan N, Ahmed AR, Denton M, Taneja V. Management and Outcomes of ANCA-Associated Vasculitis at a Tertiary Healthcare Facility. Autoimmune Diseases 2022;2022:1-7. [DOI: 10.1155/2022/4808806] [Reference Citation Analysis]
56 Prabhahar A, Naidu GSRSNK, Chauhan P, Sekar A, Sharma A, Sharma A, Kumar A, Nada R, Rathi M, Kohli HS, Ramachandran R. ANCA-associated vasculitis following ChAdOx1 nCoV19 vaccination: case-based review. Rheumatol Int. [DOI: 10.1007/s00296-021-05069-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
57 Li W, Zhang Q, Xie L, Fan N, Liu Z, Zhang L, Zhang J, Tang S, Wang W, Liu X, Li X, Wang H, Zhao J, Huang Y, Zhang J. Clinical significance and role of CXCL16 in anti-neutrophil cytoplasmic autoantibody-associated vasculitis. Immunol Lett 2022:S0165-2478(22)00011-6. [PMID: 35120907 DOI: 10.1016/j.imlet.2022.01.003] [Reference Citation Analysis]
58 Harada M, Nakajima T, Yamada Y, Aomura D, Yamaguchi A, Sonoda K, Tanaka N, Hashimoto K, Kamijo Y. Serum Sulfatide Levels as a Biomarker of Active Glomerular Lesion in Patients with Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis: A Single Center Pilot Study. JCM 2022;11:762. [DOI: 10.3390/jcm11030762] [Reference Citation Analysis]
59 de Souza AWS, Zarur EB, Pimentel-Quiroz VR, Sanchez-Torres A, Ugarte-Gil MF, Sato EI. Different epidemiologic profiles of systemic vasculitis between Brazil and Peru-preliminary results in two referral centers from both countries. Clin Rheumatol 2022. [PMID: 35083562 DOI: 10.1007/s10067-021-06032-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
60 Yang K, Han J, Asada M, Gill JG, Park JY, Sathe MN, Gattineni J, Wright T, Wysocki CA, de la Morena MT, Garza LA, Yan N. Cytoplasmic RNA quality control failure engages mTORC1-mediated autoinflammatory disease. J Clin Invest 2022;132:e146176. [PMID: 35040435 DOI: 10.1172/JCI146176] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
61 Faycal CA, Oszwald A, Feilen T, Contreras MJC, Schilling O, Loustau T, Steinbach F, Schachner H, Langer B, Heeringa P, Rees AJ, Orend G, Kain R. An adapted passive model of anti-MPO dependent crescentic glomerulonephritis reveals matrix dysregulation and is amenable to modulation by CXCR4 inhibition. Matrix Biol 2022:S0945-053X(22)00001-4. [PMID: 35032611 DOI: 10.1016/j.matbio.2022.01.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
62 Kumar M, Mondal S, Sircar G, Ghorai S, Haldar S, Ghosh A. Microscopic Polyangiitis with Pulmonary-renal Involvement in a Patient with Polyarticular Juvenile Idiopathic Arthritis: A Case Report. Indian J Nephrol 2022;0:0. [DOI: 10.4103/ijn.ijn_414_21] [Reference Citation Analysis]
63 Shochet L, Kitching AR. Animal models of vasculitis. Curr Opin Rheumatol 2022;34:10-7. [PMID: 34783711 DOI: 10.1097/BOR.0000000000000848] [Reference Citation Analysis]
64 Bayrashevskaya A, Degtyareva N, Radenska-lopovok S. ANCA-associated small-vessel vasculitides. Arkh patol 2022;84:50. [DOI: 10.17116/patol20228401150] [Reference Citation Analysis]
65 Kadura S, Raghu G. Antineutrophil cytoplasmic antibody-associated interstitial lung disease: a review. Eur Respir Rev 2021;30:210123. [PMID: 34750115 DOI: 10.1183/16000617.0123-2021] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
66 Molnár A, Thomas MJ, Fintha A, Kardos M, Dobi D, Tislér A, Ledó N. Kidney biopsy-based epidemiologic analysis shows growing biopsy rate among the elderly. Sci Rep 2021;11. [DOI: 10.1038/s41598-021-04274-9] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
67 Weng J, Du Z, Zhang Y. CNS limited ANCA-associated vasculitis presenting as an isolated intraparenchymal mass. J Neuroimmunol 2021;364:577791. [PMID: 34999284 DOI: 10.1016/j.jneuroim.2021.577791] [Reference Citation Analysis]
68 Ahn SS, Song JJ, Park YB, Lee SW. Clinical impact of proteinase 3-antineutrophil cytoplasmic antibody positivity in eosinophilic granulomatosis with polyangiitis. Korean J Intern Med 2021. [PMID: 34883552 DOI: 10.3904/kjim.2021.043] [Reference Citation Analysis]
69 Hughes M, Kahaleh B, Denton CP, Mason JC, Matucci-Cerinic M. ANCA in systemic sclerosis, when vasculitis overlaps with vasculopathy: a devastating combination of pathologies. Rheumatology (Oxford) 2021;60:5509-16. [PMID: 33744916 DOI: 10.1093/rheumatology/keab278] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
70 Berti A, Hillion S, Hummel AM, Son YM, Chriti N, Peikert T, Carmona EM, Abdulahad WH, Heeringa P, Harris KM, St Clair EW, Brunetta P, Fervenza FC, Langford CA, Kallenberg CG, Merkel PA, Monach PA, Seo P, Spiera RF, Stone JH, Grandi G, Sun J, Pers JO, Specks U, Cornec D; RAVE-ITN Research Group. Circulating autoreactive proteinase 3+ B cells and tolerance checkpoints in ANCA-associated vasculitis. JCI Insight 2021;6:e150999. [PMID: 34618687 DOI: 10.1172/jci.insight.150999] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
71 Zhang Y, Guo J, Zhang P, Zhang L, Duan X, Shi X, Guo N, Liu S. Predictors of Mortality in Critically Ill Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis. Front Med (Lausanne) 2021;8:762004. [PMID: 34760903 DOI: 10.3389/fmed.2021.762004] [Reference Citation Analysis]
72 Valladales-restrepo LF, Medina-morales DA, Constain-mosquera C, Vargas-díaz K, Peña-verjan NM, Saldarriaga-rivera LM, Machado-alba JE. Pattern of prescription drugs used for patients diagnosed with systemic vasculitis. Revista Colombiana de Reumatología 2021. [DOI: 10.1016/j.rcreu.2021.08.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
73 Wu X, Mancuso E, Armendi I, Krasinski D, Liu L, Tarsi S, Waz WR, Abdul-Aziz R, Elenberg E. Renal Involvement and Its Treatment in Pediatric Patients With Proteinase-3 Anti-Neutrophil Cytoplasmic Antibody Positive Granulomatosis With Polyangiitis: A Case Series. Cureus 2021;13:e18197. [PMID: 34707966 DOI: 10.7759/cureus.18197] [Reference Citation Analysis]
74 Sorin B, Samson M, Durel CA, Diot E, Guichard I, Grados A, Limal N, Régent A, Cohen P, Dion J, Legendre P, Le Guern V, Mouthon L, Guillevin L, Terrier B; French Vasculitis Study Group (FVSG). Rituximab plus methotrexate combination as a salvage therapy in persistently active granulomatosis with polyangiitis. Rheumatology (Oxford) 2021:keab791. [PMID: 34698818 DOI: 10.1093/rheumatology/keab791] [Reference Citation Analysis]
75 Kimura K, Fujii Y, Maekawa M, Tsukamoto H. Successful Rituximab Treatment in a Patient With ANCA-Negative Granulomatosis With Polyangitis: A Case Report. Mod Rheumatol Case Rep 2021:rxab034. [PMID: 34673983 DOI: 10.1093/mrcr/rxab034] [Reference Citation Analysis]
76 Kang Z, Li Z. Reduced-Dose vs High-Dose Glucocorticoids Added to Rituximab and Remission Induction in ANCA-Associated Vasculitis. JAMA 2021;326:1535-6. [PMID: 34665209 DOI: 10.1001/jama.2021.13867] [Reference Citation Analysis]
77 Guzman-Soto MI, Kimura Y, Romero-Sanchez G, Cienfuegos-Alvear JA, Candanedo-Gonzalez F, Kimura-Sandoval Y, Sanchez-Nava DA, Alonso-Ramon I, Hinojosa-Azaola A. From Head to Toe: Granulomatosis with Polyangiitis. Radiographics 2021;41:1973-91. [PMID: 34652975 DOI: 10.1148/rg.2021210132] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
78 Yoon T, Lee LE, Ahn SS, Pyo JY, Song JJ, Park YB, Lee SW. Serum progranulin as a predictive marker for high activity of antineutrophil cytoplasmic antibody-associated vasculitis. J Clin Lab Anal 2021;35:e24048. [PMID: 34626000 DOI: 10.1002/jcla.24048] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
79 Yap BJM, Lai-Foenander AS, Goh BH, Ong YS, Duangjai A, Saokaew S, Chua CLL, Phisalprapa P, Yap WH. Unraveling the Immunopathogenesis and Genetic Variants in Vasculitis Toward Development of Personalized Medicine. Front Cardiovasc Med 2021;8:732369. [PMID: 34621800 DOI: 10.3389/fcvm.2021.732369] [Reference Citation Analysis]
80 Dirikgil E, Jonker JT, Tas SW, Verburgh CA, Soonawala D, Hak AE, Remmelts HHF, IJpelaar D, Laverman GD, Rutgers A, van Laar JM, Moen HJB, Verhoeven PMJ, Rabelink TJ, Bos WJW, Teng YKO; Arthritis Research & Collaboration Hub (ARCH) study group. Clinical Practice Audit on the Management of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis in the Netherlands. Kidney Int Rep 2021;6:2671-8. [PMID: 34622106 DOI: 10.1016/j.ekir.2021.08.002] [Reference Citation Analysis]
81 Gulati K, Edwards H, Prendecki M, Cairns TD, Condon M, Galliford J, Griffith M, Levy JB, Tam FWK, Tanna A, Pusey CD, McAdoo SP. Combination treatment with rituximab, low-dose cyclophosphamide and plasma exchange for severe antineutrophil cytoplasmic antibody-associated vasculitis. Kidney Int 2021;100:1316-24. [PMID: 34560140 DOI: 10.1016/j.kint.2021.08.025] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
82 Kitching AR, Hickey MJ. Immune cell behaviour and dynamics in the kidney - insights from in vivo imaging. Nat Rev Nephrol 2021. [PMID: 34556836 DOI: 10.1038/s41581-021-00481-9] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
83 Alikhan MA, Jaw J, Shochet LR, Robson KJ, Ooi JD, Brouwer E, Heeringa P, Holdsworth SR, Kitching AR. Ageing enhances cellular immunity to myeloperoxidase and experimental anti-myeloperoxidase glomerulonephritis. Rheumatology (Oxford) 2021:keab682. [PMID: 34508583 DOI: 10.1093/rheumatology/keab682] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
84 Vlasschaert C, Moran SM, Rauh MJ. The Myeloid-Kidney Interface in Health and Disease. Clin J Am Soc Nephrol 2021:CJN. [PMID: 34507968 DOI: 10.2215/CJN.04120321] [Reference Citation Analysis]
85 Kant S, Kronbichler A, Sharma P, Geetha D. Advances in Understanding of Pathogenesis and Treatment of Immune-Mediated Kidney Disease: A Review. Am J Kidney Dis 2021:S0272-6386(21)00835-0. [PMID: 34508831 DOI: 10.1053/j.ajkd.2021.07.019] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
86 Moura MC, Fervenza FC, Specks U, Sethi S. Kidney Biopsy Chronicity Grading in Antineutrophil Cytoplasmic Antibody Associated Vasculitis. Nephrol Dial Transplant 2021:gfab250. [PMID: 34436585 DOI: 10.1093/ndt/gfab250] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
87 Argyropoulou OD, Goules AV, Boutzios G, Tsirogianni A, Sfontouris C, Manoussakis MN, Vlachoyiannopoulos PG, Tzioufas AG, Kapsogeorgou EK. Occurrence and Antigenic Specificity of Perinuclear Anti-Neutrophil Cytoplasmic Antibodies (P-ANCA) in Systemic Autoimmune Diseases. Cells 2021;10:2128. [PMID: 34440897 DOI: 10.3390/cells10082128] [Reference Citation Analysis]
88 Domínguez-Quintana M, Alba MA, Hinojosa-Azaola A. Classification of ANCA-associated vasculitis: differences based on ANCA specificity and clinicopathologic phenotype. Rheumatol Int 2021;41:1717-28. [PMID: 34383129 DOI: 10.1007/s00296-021-04966-5] [Reference Citation Analysis]
89 Wang L, Li X, Song Y, Song D, Huang D. The emerging roles of semaphorin4D/CD100 in immunological diseases. Biochem Soc Trans 2020;48:2875-90. [PMID: 33258873 DOI: 10.1042/BST20200821] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
90 Rutherford MA, Scott J, Karabayas M, Antonelou M, Gopaluni S, Gray D, Barrett J, Brix SR, Dhaun N, McAdoo SP, Smith RM, Geddes CC, Jayne D, Luqmani R, Salama AD, Little MA, Basu N; UK and Ireland Vasculitis Rare Disease Group (UKIVAS). Risk Factors for Severe Outcomes in Patients With Systemic Vasculitis and COVID-19: A Binational, Registry-Based Cohort Study. Arthritis Rheumatol 2021;73:1713-9. [PMID: 33750043 DOI: 10.1002/art.41728] [Cited by in Crossref: 7] [Cited by in F6Publishing: 18] [Article Influence: 7.0] [Reference Citation Analysis]
91 Maritati F, Moretti MI, Nastasi V, Mazzucchelli R, Morroni M, Bagnarelli P, Rupoli S, Tavio M, Galiotta P, Bisello W, Ranghino A. ANCA-Associated Glomerulonephritis and Anti-Phospholipid Syndrome in a Patient with SARS-CoV-2 Infection: Just a Coincidence? Case Rep Nephrol Dial 2021;11:214-20. [PMID: 34373831 DOI: 10.1159/000517513] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
92 Liao Z, Tang J, Luo L, Deng S, Luo L, Wang F, Yuan X, Hu X, Feng J, Li X. Altered circulating CCR6+and CXCR3+ T cell subsets are associated with poor renal prognosis in MPO-ANCA-associated vasculitis. Arthritis Res Ther 2021;23:194. [PMID: 34289887 DOI: 10.1186/s13075-021-02576-x] [Reference Citation Analysis]
93 Vegting Y, Vogt L, Anders HJ, de Winther MPJ, Bemelman FJ, Hilhorst ML. Monocytes and macrophages in ANCA-associated vasculitis. Autoimmun Rev 2021;20:102911. [PMID: 34298153 DOI: 10.1016/j.autrev.2021.102911] [Reference Citation Analysis]
94 Żabińska M, Kościelska-Kasprzak K, Krajewska J, Bartoszek D, Augustyniak-Bartosik H, Krajewska M. Immune Cells Profiling in ANCA-Associated Vasculitis Patients-Relation to Disease Activity. Cells 2021;10:1773. [PMID: 34359942 DOI: 10.3390/cells10071773] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
95 Huang X, Chen L, Lan L, Ren P, Ni A, Ma Y, Wang Y, Zhu Y, Xu Y, Chen J, Han F. Antineutrophil Cytoplasmic Antibody-Associated Vasculitis With Acute Kidney Injury: Short-Term Recovery Predicts Long-Term Outcome. Front Immunol 2021;12:641655. [PMID: 34305886 DOI: 10.3389/fimmu.2021.641655] [Reference Citation Analysis]
96 Dekkema GJ, Rutgers A, Sanders JS, Stegeman CA, Heeringa P. The Nasal Microbiome in ANCA-Associated Vasculitis: Picking the Nose for Clues on Disease Pathogenesis. Curr Rheumatol Rep 2021;23:54. [PMID: 34196846 DOI: 10.1007/s11926-021-01015-9] [Reference Citation Analysis]
97 Boudhabhay I, Delestre F, Coutance G, Gnemmi V, Quemeneur T, Vandenbussche C, Lazareth H, Canaud G, Tricot L, Gosset C, Hummel A, Terrier B, Rabant M, van Daalen EE, Wester Trejo MAC, Bajema IM, Karras A, Duong Van Huyen JP. Reappraisal of Renal Arteritis in ANCA-associated Vasculitis: Clinical Characteristics, Pathology, and Outcome. J Am Soc Nephrol 2021;32:2362-74. [PMID: 34155059 DOI: 10.1681/ASN.2020071074] [Cited by in F6Publishing: 10] [Reference Citation Analysis]
98 Ahn SS, Yoon T, Song JJ, Park YB, Lee SW. Association Between Serum Alarmin Levels and Disease-specific Indices in Patients With Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis. In Vivo 2021;35:1761-8. [PMID: 33910860 DOI: 10.21873/invivo.12435] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
99 Egan AC, Peters J, Jolly E, Flint S, Sivasothy P, Jayne DRW. A critical beat in eosinophilic granulomatosis with polyangiitis. Rheumatology (Oxford) 2021;60:iii28-31. [PMID: 34137885 DOI: 10.1093/rheumatology/keab180] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
100 Gulati K, Roufosse C, McAdoo SP. Diffuse crescentic glomerulonephritis presenting with preserved renal function. Rheumatology (Oxford) 2021;60:iii18-20. [PMID: 34137881 DOI: 10.1093/rheumatology/keab105] [Reference Citation Analysis]
101 Egan AC, Smith RM, Jayne DRW. Introduction to the European Vasculitis Society 3rd International Vasculitis Course (Cambridge) case-based supplement. Rheumatology (Oxford) 2021;60:iii1-5. [PMID: 34137887 DOI: 10.1093/rheumatology/keab331] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
102 Müller A, Krause B, Kerstein-Stähle A, Comdühr S, Klapa S, Ullrich S, Holl-Ulrich K, Lamprecht P. Granulomatous Inflammation in ANCA-Associated Vasculitis. Int J Mol Sci 2021;22:6474. [PMID: 34204207 DOI: 10.3390/ijms22126474] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
103 Zhao Y, Panzer U, Bonn S, Krebs CF. Single-cell biology to decode the immune cellular composition of kidney inflammation. Cell Tissue Res 2021. [PMID: 34125286 DOI: 10.1007/s00441-021-03483-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
104 Anders HJ, Nakazawa D. Being an ADVOCATE for People with ANCA Vasculitis. Clin J Am Soc Nephrol 2021;16:1581-3. [PMID: 34083218 DOI: 10.2215/CJN.03670321] [Reference Citation Analysis]
105 Gori T. Coronary Vasculitis. Biomedicines 2021;9:622. [PMID: 34072772 DOI: 10.3390/biomedicines9060622] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
106 Liu Z, Guo M, Cai Y, Zhao Y, Zeng F, Liu Y. A nomogram to predict the risk of lupus enteritis in systemic lupus erythematosus patients with gastroinctestinal involvement. EClinicalMedicine 2021;36:100900. [PMID: 34041462 DOI: 10.1016/j.eclinm.2021.100900] [Reference Citation Analysis]
107 Heron V, Gingold M, Kitching AR, Polkinghorne KR, Ryan J. The impact of antineutrophil cytoplasmic antibody-associated vasculitis on employment and work disability in an Australian population. Int J Rheum Dis 2021;24:904-11. [PMID: 34019342 DOI: 10.1111/1756-185X.14131] [Reference Citation Analysis]
108 Bonasia CG, Abdulahad WH, Rutgers A, Heeringa P, Bos NA. B Cell Activation and Escape of Tolerance Checkpoints: Recent Insights from Studying Autoreactive B Cells. Cells 2021;10:1190. [PMID: 34068035 DOI: 10.3390/cells10051190] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
109 Specks U, Fussner LA, Cartin-Ceba R, Casal Moura M, Zand L, Fervenza FC. Plasma exchange for the management of ANCA-associated vasculitis: the con position. Nephrol Dial Transplant 2021;36:231-6. [PMID: 33374017 DOI: 10.1093/ndt/gfaa312] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
110 Ota M, Nagafuchi Y, Hatano H, Ishigaki K, Terao C, Takeshima Y, Yanaoka H, Kobayashi S, Okubo M, Shirai H, Sugimori Y, Maeda J, Nakano M, Yamada S, Yoshida R, Tsuchiya H, Tsuchida Y, Akizuki S, Yoshifuji H, Ohmura K, Mimori T, Yoshida K, Kurosaka D, Okada M, Setoguchi K, Kaneko H, Ban N, Yabuki N, Matsuki K, Mutoh H, Oyama S, Okazaki M, Tsunoda H, Iwasaki Y, Sumitomo S, Shoda H, Kochi Y, Okada Y, Yamamoto K, Okamura T, Fujio K. Dynamic landscape of immune cell-specific gene regulation in immune-mediated diseases. Cell 2021;184:3006-3021.e17. [PMID: 33930287 DOI: 10.1016/j.cell.2021.03.056] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
111 Karpman D, Tontanahal A. Extracellular vesicles in renal inflammatory and infectious diseases. Free Radic Biol Med 2021;171:42-54. [PMID: 33933600 DOI: 10.1016/j.freeradbiomed.2021.04.032] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
112 Wu J, Pei Y, Rong L, Zhuang H, Zeng S, Chen L, Jiang X. Clinicopathological Analysis of 34 Cases of Primary Antineutrophil Cytoplasmic Antibody-Associated Vasculitis in Chinese Children. Front Pediatr 2021;9:656307. [PMID: 33981654 DOI: 10.3389/fped.2021.656307] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
113 Kawanishi K, Nishiwaki H, Kawata N, Omiya S, Inoue Y, Koiwa F. Granulomatosis with polyangiitis in a patient with a thoracic vertebral lesion: a case report. Mod Rheumatol Case Rep 2021;5:347-53. [PMID: 33886441 DOI: 10.1080/24725625.2021.1911426] [Reference Citation Analysis]
114 Long Y, Feng J, Ma Y, Sun Y, Xu L, Song Y, Liu C. Altered follicular regulatory T (Tfr)- and helper T (Tfh)-cell subsets are associated with autoantibody levels in microscopic polyangiitis patients. Eur J Immunol 2021;51:1809-23. [PMID: 33764509 DOI: 10.1002/eji.202049093] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
115 Coskun Benlidayi I. What are the benefits and harms of anti-cytokine targeted therapies for adults with anti-neutrophil cytoplasmic antibody-associated vasculitis? - A Cochrane Review summary with commentary. Int J Rheum Dis 2021;24:724-7. [PMID: 33835676 DOI: 10.1111/1756-185X.14098] [Reference Citation Analysis]
116 Almaani S, Fussner LA, Brodsky S, Meara AS, Jayne D. ANCA-Associated Vasculitis: An Update. J Clin Med 2021;10:1446. [PMID: 33916214 DOI: 10.3390/jcm10071446] [Cited by in F6Publishing: 13] [Reference Citation Analysis]
117 Li W, Huang H, Cai M, Yuan T, Sheng Y. Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Update: Genetic Pathogenesis. Front Immunol 2021;12:624848. [PMID: 33841406 DOI: 10.3389/fimmu.2021.624848] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
118 Lin W, Shen C, Zhong Y, Ooi JD, Eggenhuizen P, Zhou YO, Luo H, Huang J, Chen JB, Wu T, Meng T, Xiao Z, Ao X, Peng W, Tang R, Yin H, Xiao X, Zhou Q, Xiao P. Glomerular Immune Deposition in MPO-ANCA Associated Glomerulonephritis Is Associated With Poor Renal Survival. Front Immunol 2021;12:625672. [PMID: 33841408 DOI: 10.3389/fimmu.2021.625672] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
119 Reitsema RD, Boots AMH, van der Geest KSM, Sandovici M, Heeringa P, Brouwer E. CD8+ T Cells in GCA and GPA: Bystanders or Active Contributors? Front Immunol 2021;12:654109. [PMID: 33815414 DOI: 10.3389/fimmu.2021.654109] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
120 Kawasaki A, Tsuchiya N. Advances in the genomics of ANCA-associated vasculitis-a view from East Asia. Genes Immun 2021;22:1-11. [PMID: 33686257 DOI: 10.1038/s41435-021-00123-x] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
121 Cheung CK, McAdoo SP. Maintenance rituximab treatment for ANCA-associated vasculitis: to be continued? Rheumatology (Oxford) 2021;60:1010-2. [PMID: 33351955 DOI: 10.1093/rheumatology/keaa812] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
122 Fagni F, Bello F, Emmi G. Eosinophilic Granulomatosis With Polyangiitis: Dissecting the Pathophysiology. Front Med (Lausanne) 2021;8:627776. [PMID: 33718405 DOI: 10.3389/fmed.2021.627776] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
123 Obrișcă B, Vornicu A, Jurubiță R, Achim C, Bobeică R, Andronesi A, Sorohan B, Herlea V, Procop A, Dina C, Ismail G. Corticosteroids are the major contributors to the risk for serious infections in autoimmune disorders with severe renal involvement. Clin Rheumatol 2021;40:3285-97. [PMID: 33595739 DOI: 10.1007/s10067-021-05646-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
124 Demir AM, Aydin F, Acar B, Kurt T, Poyraz A, Kiremitci S, Gülleroglu B, Azili MN, Bayrakci US. IgG4-related disease and ANCA positive vasculitis in childhood: a case-based review. Clin Rheumatol 2021;40:3817-25. [PMID: 33590421 DOI: 10.1007/s10067-021-05635-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
125 Nagano K, Tsutsumi Y. Phage Display Technology as a Powerful Platform for Antibody Drug Discovery. Viruses 2021;13:178. [PMID: 33504115 DOI: 10.3390/v13020178] [Cited by in Crossref: 4] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
126 Scullion KM, Vliegenthart ADB, Rivoli L, Oosthuyzen W, Farrah TE, Czopek A, Webb DJ, Hunter RW, Bailey MA, Dhaun N, Dear JW. Circulating argonaute-bound microRNA-126 reports vascular dysfunction and treatment response in acute and chronic kidney disease. iScience 2021;24:101937. [PMID: 33392483 DOI: 10.1016/j.isci.2020.101937] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
127 Gauckler P, Bettac EL, Nairz M, Duftner C, Luger AK, Stein M, Wanner D, Böckle BC, Tiefenthaler M, Schratzberger P, Neuwirt H, Harasser L, Mayer G, Kronbichler A. What comes after the lockdown? Clustering of ANCA-associated vasculitis: single-centre observation of a spatiotemporal pattern. Ann Rheum Dis 2021;80:669-71. [PMID: 33262111 DOI: 10.1136/annrheumdis-2020-219212] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
128 Manrique J, Chan E, Hartzell S, Mon-Wei Yu S, Cantarelli C, Fernandez LF, Slon MF, Purroy C, Tassiulas I, Azzi J, Riella LV, Maggiore U, Cravedi P. Circulating B Cells, Plasma Cells, and Treg Associate with ANCA Levels in ANCA-associated Vasculitis. Kidney Int Rep 2021;6:496-500. [PMID: 33615075 DOI: 10.1016/j.ekir.2020.11.016] [Reference Citation Analysis]
129 Liu Y, Kaplan MJ. Neutrophils in the Pathogenesis of Rheumatic Diseases: Fueling the Fire. Clinic Rev Allerg Immunol 2021;60:1-16. [DOI: 10.1007/s12016-020-08816-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
130 Noce A, Santoro ML, Marrone G, D'Agostini C, Amelio I, Duggento A, Tesauro M, Di Daniele N. Serological determinants of COVID-19. Biol Direct 2020;15:21. [PMID: 33138856 DOI: 10.1186/s13062-020-00276-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]